EW ▼ -0.5% - Edwards Lifesciences Corporation
$EW FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
21-OCT-2026 09:01 AM ET
Share this post
More filings for $EW
EW ▼ -0.5% - Edwards Lifesciences CorporationOct 21, 2026EW ▼ -0.0% - Edwards Lifesciences CorporationOct 7, 2026EW ▲ +0.3% - Edwards Lifesciences CorporationOct 5, 2026EW ▼ -0.1% - Edwards Lifesciences CorporationOct 5, 2026EW ▼ -1.3% - Edwards Lifesciences CorporationOct 1, 2026EW ▼ -1.3% - Edwards Lifesciences CorporationOct 1, 2026
View full $EW filing history →💬 Comments
Loading comments…
Leave a comment